|
|
||||||||
Papers In Press, published online ahead of print November 1, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VAMC-111F, San Francisco, CA 94121
Corresponding Author: skerick{at}itsa.ucsf.edu
The CYP27A gene encodes a mitochondrial cytochrome P450 enzyme, sterol 27-hydroxylase, that is expressed in many different tissues and plays an important role in cholesterol and bile acid metabolism. In humans, CYP27A deficiency leads to cerebrotendinous xanthomatosis. To gain insight into roles of CYP27A in regulation of cholesterol and bile acid metabolism, cyp27A gene knockout heterozygous, homozygous and wild type littermate mice were studied. In contrast to homozygotes, heterozygotes had increased body weights and were mildly hypercholesterolemic with increased numbers of lipoprotein particles in the low density lipoprotein size range. Cyp7A expression was not increased in heterozygotes, but it was in homozygotes suggesting parts of the homozygous phenotype are secondary to increased cyp7A expression and activity. Homozygotes exhibited pronounced hepatomegaly and dysregulation in hepatic cholesterol, bile acid and fatty acid metabolism. Hepatic cholesterol synthesis and synthesis of bile acid intermediates were elevated; however, side chain cleavage was impaired leading to decreased bile salt concentrations in gallbladder bile. Expression of Ntcp, the major sinusoidal bile salt transporter was increased and that of Bsep, the major canalicular bile salt transporter, decreased. Gender played a modifying role in homozygous response to cyp27A deficiency, with females being generally more severely impacted. Thus, both cyp27A genotype and gender impacted regulation of hepatic bile acid, cholesterol and fatty acid metabolism.
Revised on October 18, 2004
Accepted on October 18, 2004
Role of CYP27A in cholesterol and bile acid metabolism
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
X. Li, W. M. Pandak, S. K. Erickson, Y. Ma, L. Yin, P. Hylemon, and S. Ren Biosynthesis of the regulatory oxysterol, 5-cholesten-3{beta},25-diol 3-sulfate, in hepatocytes J. Lipid Res., December 1, 2007; 48(12): 2587 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ikonen Mechanisms for cellular cholesterol transport: defects and human disease. Physiol Rev, October 1, 2006; 86(4): 1237 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, P. Hylemon, W. M. Pandak, and S. Ren Enzyme activity assay for cholesterol 27-hydroxylase in mitochondria J. Lipid Res., July 1, 2006; 47(7): 1507 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ren, P. Hylemon, Z.-P. Zhang, D. Rodriguez-Agudo, D. Marques, X. Li, H. Zhou, G. Gil, and W. M. Pandak Identification of a novel sulfonated oxysterol, 5-cholesten-3{beta},25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria J. Lipid Res., May 1, 2006; 47(5): 1081 - 1090. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |